Clinical trials: Understanding and perceptions of female Chinese-American cancer patients

Shin-Ping Tu, Hueifang Chen, Anthony Chen, Jeanette Lim, Suepattra May, Charles Drescher

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Under-representation of minority and female participants prompted the U.S. legislature to mandate the inclusion of women and minorities in federally funded research. Recruitment of minorities to participate in clinical trials continues to be challenging. Although Asian Americans constitute one of the major minority groups in the U.S., published literature contains sparse data concerning the participation of Asian Americans in cancer clinical trials. The authors completed qualitative, semistructured interviews with 34 participants: Chinese-American female cancer patients ages 20-85 years or their family members. Interviews were conducted in Cantonese, Mandarin, or English and were audiotaped. Chinese interviews were translated into English, and all interviews were transcribed subsequently into English. A team of five coders individually reviewed then met to discuss the English transcripts. The authors used the constant comparative technique throughout the entire coding process as part of the analysis. Among participants, 62% lacked any knowledge of clinical trials, and many expressed negative attitudes toward clinical trials. Barriers to participation included inadequate resources, language issues, and a lack of financial and social support. Facilitating factors included recommendations by a trusted oncologist or another trusted individual and information in the appropriate language. It is noteworthy that family members played an important role in the cancer experience of these participants. To promote participation, there is a need to increase knowledge of clinical trials among Chinese cancer patients. It also is necessary to examine the applicability of current patient-physician communication and interaction models. In addition, decision-making based on Asian philosophies within the context of Euro-American bioethics requires further study.

Original languageEnglish (US)
Pages (from-to)2999-3005
Number of pages7
JournalCancer
Volume104
Issue number12 SUPPL.
DOIs
StatePublished - Dec 15 2005
Externally publishedYes

Fingerprint

Asian Americans
Clinical Trials
Interviews
Neoplasms
Language
Financial Support
Minority Groups
Bioethics
Social Support
Decision Making
Communication
Physicians
Research

Keywords

  • Asian Americans
  • Clinical trials
  • Patient participation
  • Traditional Chinese medicine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Tu, S-P., Chen, H., Chen, A., Lim, J., May, S., & Drescher, C. (2005). Clinical trials: Understanding and perceptions of female Chinese-American cancer patients. Cancer, 104(12 SUPPL.), 2999-3005. https://doi.org/10.1002/cncr.21524

Clinical trials : Understanding and perceptions of female Chinese-American cancer patients. / Tu, Shin-Ping; Chen, Hueifang; Chen, Anthony; Lim, Jeanette; May, Suepattra; Drescher, Charles.

In: Cancer, Vol. 104, No. 12 SUPPL., 15.12.2005, p. 2999-3005.

Research output: Contribution to journalArticle

Tu, S-P, Chen, H, Chen, A, Lim, J, May, S & Drescher, C 2005, 'Clinical trials: Understanding and perceptions of female Chinese-American cancer patients', Cancer, vol. 104, no. 12 SUPPL., pp. 2999-3005. https://doi.org/10.1002/cncr.21524
Tu, Shin-Ping ; Chen, Hueifang ; Chen, Anthony ; Lim, Jeanette ; May, Suepattra ; Drescher, Charles. / Clinical trials : Understanding and perceptions of female Chinese-American cancer patients. In: Cancer. 2005 ; Vol. 104, No. 12 SUPPL. pp. 2999-3005.
@article{fcce8f62235848459e3619e0a20558c9,
title = "Clinical trials: Understanding and perceptions of female Chinese-American cancer patients",
abstract = "Under-representation of minority and female participants prompted the U.S. legislature to mandate the inclusion of women and minorities in federally funded research. Recruitment of minorities to participate in clinical trials continues to be challenging. Although Asian Americans constitute one of the major minority groups in the U.S., published literature contains sparse data concerning the participation of Asian Americans in cancer clinical trials. The authors completed qualitative, semistructured interviews with 34 participants: Chinese-American female cancer patients ages 20-85 years or their family members. Interviews were conducted in Cantonese, Mandarin, or English and were audiotaped. Chinese interviews were translated into English, and all interviews were transcribed subsequently into English. A team of five coders individually reviewed then met to discuss the English transcripts. The authors used the constant comparative technique throughout the entire coding process as part of the analysis. Among participants, 62{\%} lacked any knowledge of clinical trials, and many expressed negative attitudes toward clinical trials. Barriers to participation included inadequate resources, language issues, and a lack of financial and social support. Facilitating factors included recommendations by a trusted oncologist or another trusted individual and information in the appropriate language. It is noteworthy that family members played an important role in the cancer experience of these participants. To promote participation, there is a need to increase knowledge of clinical trials among Chinese cancer patients. It also is necessary to examine the applicability of current patient-physician communication and interaction models. In addition, decision-making based on Asian philosophies within the context of Euro-American bioethics requires further study.",
keywords = "Asian Americans, Clinical trials, Patient participation, Traditional Chinese medicine",
author = "Shin-Ping Tu and Hueifang Chen and Anthony Chen and Jeanette Lim and Suepattra May and Charles Drescher",
year = "2005",
month = "12",
day = "15",
doi = "10.1002/cncr.21524",
language = "English (US)",
volume = "104",
pages = "2999--3005",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12 SUPPL.",

}

TY - JOUR

T1 - Clinical trials

T2 - Understanding and perceptions of female Chinese-American cancer patients

AU - Tu, Shin-Ping

AU - Chen, Hueifang

AU - Chen, Anthony

AU - Lim, Jeanette

AU - May, Suepattra

AU - Drescher, Charles

PY - 2005/12/15

Y1 - 2005/12/15

N2 - Under-representation of minority and female participants prompted the U.S. legislature to mandate the inclusion of women and minorities in federally funded research. Recruitment of minorities to participate in clinical trials continues to be challenging. Although Asian Americans constitute one of the major minority groups in the U.S., published literature contains sparse data concerning the participation of Asian Americans in cancer clinical trials. The authors completed qualitative, semistructured interviews with 34 participants: Chinese-American female cancer patients ages 20-85 years or their family members. Interviews were conducted in Cantonese, Mandarin, or English and were audiotaped. Chinese interviews were translated into English, and all interviews were transcribed subsequently into English. A team of five coders individually reviewed then met to discuss the English transcripts. The authors used the constant comparative technique throughout the entire coding process as part of the analysis. Among participants, 62% lacked any knowledge of clinical trials, and many expressed negative attitudes toward clinical trials. Barriers to participation included inadequate resources, language issues, and a lack of financial and social support. Facilitating factors included recommendations by a trusted oncologist or another trusted individual and information in the appropriate language. It is noteworthy that family members played an important role in the cancer experience of these participants. To promote participation, there is a need to increase knowledge of clinical trials among Chinese cancer patients. It also is necessary to examine the applicability of current patient-physician communication and interaction models. In addition, decision-making based on Asian philosophies within the context of Euro-American bioethics requires further study.

AB - Under-representation of minority and female participants prompted the U.S. legislature to mandate the inclusion of women and minorities in federally funded research. Recruitment of minorities to participate in clinical trials continues to be challenging. Although Asian Americans constitute one of the major minority groups in the U.S., published literature contains sparse data concerning the participation of Asian Americans in cancer clinical trials. The authors completed qualitative, semistructured interviews with 34 participants: Chinese-American female cancer patients ages 20-85 years or their family members. Interviews were conducted in Cantonese, Mandarin, or English and were audiotaped. Chinese interviews were translated into English, and all interviews were transcribed subsequently into English. A team of five coders individually reviewed then met to discuss the English transcripts. The authors used the constant comparative technique throughout the entire coding process as part of the analysis. Among participants, 62% lacked any knowledge of clinical trials, and many expressed negative attitudes toward clinical trials. Barriers to participation included inadequate resources, language issues, and a lack of financial and social support. Facilitating factors included recommendations by a trusted oncologist or another trusted individual and information in the appropriate language. It is noteworthy that family members played an important role in the cancer experience of these participants. To promote participation, there is a need to increase knowledge of clinical trials among Chinese cancer patients. It also is necessary to examine the applicability of current patient-physician communication and interaction models. In addition, decision-making based on Asian philosophies within the context of Euro-American bioethics requires further study.

KW - Asian Americans

KW - Clinical trials

KW - Patient participation

KW - Traditional Chinese medicine

UR - http://www.scopus.com/inward/record.url?scp=29144432806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144432806&partnerID=8YFLogxK

U2 - 10.1002/cncr.21524

DO - 10.1002/cncr.21524

M3 - Article

C2 - 16247796

AN - SCOPUS:29144432806

VL - 104

SP - 2999

EP - 3005

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12 SUPPL.

ER -